Public Employees Retirement Association of Colorado Decreases Stake in Mednax Inc. (MD)
Public Employees Retirement Association of Colorado decreased its position in shares of Mednax Inc. (NYSE:MD) by 0.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 508,287 shares of the company’s stock after selling 1,595 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Mednax were worth $36,815,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in MD. First Quadrant L P CA acquired a new stake in Mednax during the second quarter worth about $130,000. Morgan Dempsey Capital Management LLC raised its stake in Mednax by 147.7% in the second quarter. Morgan Dempsey Capital Management LLC now owns 2,192 shares of the company’s stock worth $159,000 after buying an additional 1,307 shares during the last quarter. Middleton & Co Inc MA acquired a new stake in Mednax during the second quarter worth about $221,000. JFS Wealth Advisors LLC acquired a new stake in Mednax during the second quarter worth about $232,000. Finally, P.R. Herzig & Co. Inc. acquired a new stake in Mednax during the second quarter worth about $239,000. Institutional investors own 97.75% of the company’s stock.
Mednax Inc. (NYSE:MD) traded up 1.29% during trading on Monday, reaching $66.97. 138,997 shares of the company’s stock traded hands. The firm has a market cap of $6.17 billion, a PE ratio of 18.69 and a beta of 0.54. The firm has a 50 day moving average price of $65.56 and a 200-day moving average price of $68.30. Mednax Inc. has a 12 month low of $61.40 and a 12 month high of $83.20.
Mednax (NYSE:MD) last released its earnings results on Thursday, July 28th. The company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by $0.04. Mednax had a return on equity of 14.88% and a net margin of 11.17%. The business had revenue of $772 million for the quarter, compared to analyst estimates of $775.68 million. During the same period in the prior year, the firm posted $0.90 EPS. Mednax’s revenue was up 14.1% on a year-over-year basis. On average, analysts forecast that Mednax Inc. will post $4.14 earnings per share for the current fiscal year.
A number of analysts have recently issued reports on MD shares. Zacks Investment Research lowered Mednax from a “buy” rating to a “hold” rating in a report on Saturday, July 30th. Mizuho restated a “buy” rating and issued a $79.00 target price on shares of Mednax in a report on Tuesday, September 20th. Jefferies Group reduced their target price on Mednax from $80.00 to $75.00 and set a “buy” rating for the company in a report on Friday, August 26th. JPMorgan Chase & Co. cut their price objective on Mednax from $85.00 to $80.00 and set an “overweight” rating for the company in a report on Friday, July 29th. Finally, Citigroup Inc. cut their price objective on Mednax from $76.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 17th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $76.11.
In other Mednax news, Director Md Pascal J. Goldschmidt sold 1,500 shares of Mednax stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $65.01, for a total transaction of $97,515.00. Following the completion of the sale, the director now owns 12,755 shares of the company’s stock, valued at approximately $829,202.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 2.40% of the company’s stock.
Mednax Company Profile
MEDNAX, Inc is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications.
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mednax Inc. (NYSE:MD).
Receive News & Ratings for Mednax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mednax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.